Lifeway Foods (LWAY) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
17 Mar, 2026Executive summary
Achieved record full year net sales of $212.5 million, up 13.7% year-over-year and 19% on a comparable basis, marking six consecutive years of volume-led growth driven by core Lifeway-branded products and Farmer Cheese.
Net income grew 54% year-over-year to $13.9 million, with Q4 net income of $2.5 million compared to a net loss in the prior year, reflecting strong operational execution.
Expanded distribution, launched new products, and entered new categories, including a licensing deal for pet nutrition and partnerships with fitness brands.
Continued investment in marketing, innovation, and retail expansion to boost brand visibility and growth.
Recognized with multiple industry awards and honors, including Dairy Foods' Processor of the Year 2025, Forbes' Best Small Companies, and Inc.'s Best in Business.
Financial highlights
Full year net sales reached $212.5 million, up 13.7% year-over-year; Q4 net sales were $55.4 million, up 18%.
Gross profit margin for the year was 27.4%, up 140 basis points; Q4 gross margin was 27.8%, up 250 basis points.
Net income for the year was $13.9 million ($0.91 per basic share), up from $9 million ($0.61 per basic share) last year.
Operating income for 2025 was $16.2 million, up from $13.9 million in 2024.
Net cash provided by operating activities was $10.9 million, down from $13.0 million in 2024; cash and cash equivalents at year-end were $5.6 million, down from $16.7 million.
Outlook and guidance
Reiterated long-term target of $45–$50 million in Adjusted EBITDA for fiscal year 2027.
Poised to deliver record-breaking sales in fiscal year 2026, with strong momentum entering the year.
Continued investment in capacity, marketing, and innovation to sustain growth.
Latest events from Lifeway Foods
- Q2 net sales rose 25.3% to $49.2M, net income hit $3.8M, and all debt was repaid.LWAY
Q2 20241 Feb 2026 - Q3 2024 sales up 12.7%, net income $3M, global expansion, and Danone bid rejected.LWAY
Q3 202414 Jan 2026 - ISS backs the full board slate for the 2025 meeting, urging shareholders to vote accordingly.LWAY
Proxy Filing19 Dec 2025 - Up to 3.45 million shares are being resold by a major shareholder as part of a governance agreement.LWAY
Registration Filing16 Dec 2025 - Board refreshes with independent directors, urges rejection of dissident nominees amid strong results.LWAY
Proxy Filing11 Dec 2025 - Proxy contest targets board overhaul, new oversight committee, and governance reforms.LWAY
Proxy Filing5 Dec 2025 - Board urges rejection of dissident nominees amid strong performance and governance refresh.LWAY
Proxy Filing2 Dec 2025 - Shareholders are solicited to replace the board, restore bylaws, and ban nepotism amid governance concerns.LWAY
Proxy Filing2 Dec 2025 - Proxy contest aims to replace board over independence concerns and strategic direction.LWAY
Proxy Filing2 Dec 2025